Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-45s75 Total loading time: 0.983 Render date: 2021-12-06T22:09:06.907Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Section 1 - Pregnancy Counseling and Contraception

Published online by Cambridge University Press:  05 March 2016

Philip J. Steer
Affiliation:
Chelsea and Westminster Hospital, London
Michael A. Gatzoulis
Affiliation:
Royal Brompton Hospital, London
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Moons, P, De Volder, E, Budts, W, et al. What do adult patients with congenital heart disease know about their disease, treatment and prevention of complications? A call for structured patient education. Heart 2001;86:7480.CrossRefGoogle Scholar
Cantwell, R, Clutton-Brock, T, Cooper, G. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl. 1):1203.Google ScholarPubMed
Health Canada. Family-Centred Maternity and Newborn Care: National Guidelines. Ottawa: Ministry of Public Works and Government Services; 2000 [www.hc-sc.gc.ca]
Siu, SC, Sermer, M, Colman, JM, et al. Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart Disease Circulation 2001;104;515–21.CrossRefGoogle ScholarPubMed
Drenthen, W, Boersma, E, Balci, A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124–32.CrossRefGoogle Scholar
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.
Drenthen, W, Pieper, PG, Roos-Hesselink, JW, et al. on behalf of the ZAHARA Investigators. Outcome of pregnancy in women with congenital heart disease: A literature review. JACC 2007;49 (24):2303–11.CrossRefGoogle ScholarPubMed
Lui, GK, Silversides, CK, Khairy, P, et al. Alliance for Adult Research in Congenital Cardiology (AARCC). Heart rate response during exercise and pregnancy outcome in women with congenital heart disease. Circulation 2011;123:242–8.CrossRefGoogle ScholarPubMed
Elkayam, U, Tummala, PP, Rao, K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567–71.CrossRefGoogle ScholarPubMed
Drife, JO, Lewis, G, Clutton-Brock, T, eds. Why Mothers Die: The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom 2000–2002. London: RCOG Press; 2004.Google Scholar
Lewis, G, ed. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH 2007.Google Scholar
Thorne, SA. Pregnancy in heart disease. Heart 2004;90:450–6.CrossRefGoogle Scholar
Nelson-Piercy, C. Cardiac disease. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer 2006–2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118(Suppl 1):109–15.Google Scholar
World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 5th edn. 2010. http://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/en/[Accessed September 25, 2015].
Faculty of Sexual & Reproductive Healthcare. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2009). 2009. www.fsrh.org/pdfs/UKMEC2009.pdf.[Accessed September 22, 2014].
Faculty of Sexual & Reproductive Healthcare. Clinical Guidance. Contraceptive choices for women with cardiac disease. June 2014. www.fsrh.org/pdfs/CEUGuidanceContraceptiveChoicesWomenCardiac Disease.pdf.[Accessed September 22, 2014].
Thorne, S, Nelson-Piercy, C, MacGregor, A, et al. Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care 2006;32:7581.CrossRefGoogle Scholar
Presbitero, P, Somerville, J, Stone, S, Aruta, E, Spiegelhalter, D, Rabajoli, F. Pregnancy in cyanotic congenital heart disease. Circulation 1994;89:2673–6.CrossRefGoogle Scholar
Peterson, HB, Xia, Z, Hughes, JM, Wilcox, LS, Tylor, LR, Trussell, J. The risk of pregnancy after tubal sterilisation: Findings from the U.S. Collaborative Review of Sterilisation.[CREST study] Am J Obstet Gynecol 1996;174:1161–70.CrossRefGoogle Scholar
Royal College of Obstetricians and Gynaecologists. Male and Female Sterilisation. Evidence-based Clinical Guidelines No. 4. London: RCOG Press; 2003.
Farmer, M, Webb, A. Intrauterine device insertion-related complications: Can they be predicted? J Fam Plann Reprod Health Care 2003;29:227–31.CrossRefGoogle Scholar
Sammut, MS, Paes, ML. Anaesthesia for laparoscopic cholecystectomy in a patient with Eisenmenger’s syndrome. Br J Anaesth 1997;79:810–12.CrossRefGoogle Scholar
Snabes, MC, Poindexter, AN 3rd. Laparoscopic tubal sterilisation under local anaesthesia in women with cyanotic heart disease. Obstet Gynecol 1991;78(3 Pt 1):437–40.Google ScholarPubMed
Duffy, S, Marsh, F, Rogerson, L, Hudson, et al. Female sterilisation: A cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 2005;112:1522–8.CrossRefGoogle ScholarPubMed
Rios-Castillo, JE, Velasco, E, Arjona-Berral, JE, Monserrat Jordan, JA, Povedano-Canizares, B, Castelo-Branco, C. Efficacy of Essure hysteroscopic sterilization: 5 years follow up of 1200 women. Gynecol Endocrinol 2013;29:580–2.CrossRefGoogle ScholarPubMed
Povedano, B, Arjona, JE, Velasco, E, Monserrat, JA, Lorente, J, Castelo-Branco, C. Complications of hysteroscopic Essure sterilization: Report on 4306 procedures performed in a single centre. BJOG 2012;119:795–9.CrossRefGoogle Scholar
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of an international multicentre case–control study. Lancet 1995;346:1575–82.
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case–control study. Lancet 1997;349:1202–9.PubMed
Lidegaard, Ø. Oral contraceptives, pregnancy and risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynaecol 1995;102:153–9.CrossRefGoogle Scholar
de Swiet, J. Paradoxical embolism associated with oral contraceptives: An underdiagnosed lesion? Postgrad Med J 1979;55:419–20.CrossRefGoogle Scholar
Lechat, P, Mas, JL, Lascault, G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148–52.CrossRefGoogle ScholarPubMed
Kerut, EK, Norfleet, WT, Plotnick, GD, Giles, TD. Patent foramen ovale: A review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613–23.CrossRefGoogle ScholarPubMed
Oelkers, W, Helmerhorst, FM, Wuttke, W, Heithecker, R. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Gynecol Endocrinol 2000;14;204–13.CrossRefGoogle Scholar
Vasilakis, C, Jick, H, del Mar Melero-Montes, M. Risk of idiopathic venous thromboembolism in users of progestogens alone. Lancet 1999;354:1610–11.CrossRefGoogle ScholarPubMed
World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case–control study. Contraception 1998;57:315–24.
Heinemann, LAJ, Assman, A, DoMinh, T, Garbe, E. Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women. Eur J Contracept Reprod Health Care 1999;4:6773.CrossRefGoogle Scholar
Dingemanse, J, van Giersbergen, PL. Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. Clin Pharmacokinet 2004;43:1089–115.CrossRefGoogle ScholarPubMed
Sorensen, MB, Collins, P, Ong, PJL, et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002;106:1646–51.CrossRefGoogle ScholarPubMed
Berenson, A, Rahman, M, Wilkinson, G. Effect of injectable and oral contraceptives on serum lipids. Am Coll Obstet Gynecol 2009;114:786–94.Google ScholarPubMed
Mantha, S, Karp, R, Raghavan, V, Terrin, N, Bauer, KA, Zwicker, JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: A meta-analysis. BMJ 2012;345:e4944.CrossRefGoogle Scholar
Van, Hylckama Vlieg A, Helmerhorst, FM, Rosendaal, FR. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonogestrel intrauterine device. Arterioscler Thromb Vasc Biol 2010;30:22972300.Google Scholar
Harrison-Woolrych, M, Zhou, L, Coulter, D. Insertion of intrauterine devices: A comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand. N Z Med J 2003;116:U538.Google ScholarPubMed
Funk, S, Miller, MM, Mishell, DR Jr, et al. The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319–26.CrossRefGoogle Scholar
Farley, TNM, Rosenberg, MJ, Rowe, PJ, Chen, JH, Meirik, O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992;339:785–8.CrossRefGoogle ScholarPubMed
Aznar, R, Reynoso, L, Ley, E, Gamez, R, De Leon, MD. Electrocardiographic changes induced by insertion of an intrauterine device and other uterine manipulations. Fertil Steril 1976;27:92–6.CrossRefGoogle Scholar
National Institute for Health and Clinical Excellence. Prophylaxis against infective endocarditis. 2008. www.nice.org.uk/guidance/cg64/resources/cg64-prophylaxis-against-infective-endocarditis-full-guidance2.[Accessed September 22, 2014].
Faculty of Sexual & Reproductive Healthcare Clinical Guidance. Emergency Contraception. August 2011, updated July 2012. www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf.[Accessed September 22, 2014].
Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428–33.PubMed
Ellison, J, Thomson, AJ, Greer, IA. Drug points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception. BMJ 2000;321:1382.CrossRefGoogle Scholar
Fine, P, Mathe, H, Ginde, S, Cullins, V, Morfesis, J, Gainer, E. Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol 2010;115:257–63.CrossRefGoogle Scholar
Glasier, AF, Cameron, ST, Logan, SJS, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: A randomised non-inferiority trial and meta-analysis. Lancet 2010;375:555–62.CrossRefGoogle ScholarPubMed
Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Evidence-based Guideline No. 7. London: RCOG; 2011. www.rcog.org.uk/globalassets/documents/guidelines/abortion-guideline_web_1.pdf.[Accessed September 22, 2014].
Bedard, E, Dimopoulos, K, Gatzoulis, MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009;30:256–65.Google Scholar
Kiely, DG, Condliffe, R, Webster, V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. BJOG 2010;117:565–74.CrossRefGoogle ScholarPubMed
Weiss, BM, Zemp, L, Seifert, B, Hess, OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650–7.CrossRefGoogle ScholarPubMed
Segal, ES, Valette, C, Oster, L, et al. Risk management strategies in the postmarketing period: Safety experience with the US and European bosentan surveillance programmes. Drug Saf 2005;28:971–80.CrossRefGoogle ScholarPubMed
Lind, J, Wallenburg, HC. The Marfan syndrome and pregnancy: A retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001;98:2835.CrossRefGoogle Scholar
Elkayam, U, Ostrzega, E, Shotan, A, Mehra, A. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 1995;123:117–22.CrossRefGoogle ScholarPubMed
Weiss, BM, von Segesser, LK, Alon, E, Seifert, B, Turina, MI. Outcome of cardiovascular surgery and pregnancy: A systematic review of the period 1984–1996. Am J Obstet Gynecol 1998;179(6 Pt 1):1643–53.CrossRefGoogle Scholar
1
Cited by

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×